ALK-Abelló A/S

ALK-B.CO Q1 2026

Reported: 2026-05-05

ALK's shares rose 7.6% after the company reported better-than-expected Q1 revenue growth and margin expansion, driven by record tablet sales and a positive update on its peanut allergy Phase II trial.

Key takeaways

Q1 revenue increased 18% to DKK 1.8 billion, led by double-digit growth across all major regions except Japan.
Tablet sales hit a milestone, surpassing DKK 1 billion for the quarter, growing 26% in both Europe and North America, despite a 17% decline in international markets due to shipment timing in Japan.
Gross margin improved 2 percentage points to 69%, supported by a favorable product mix and seasonality with higher-margin European tablets.
Operating profit grew 22%, with EBIT margin expanding to 32%, despite a 23% rise in capacity costs reflecting investments in growth initiatives.
The Phase II ALLIANCE trial for the peanut allergy tablet showed statistically significant efficacy, providing a strong strategic catalyst going forward.

View recap

Prosegur Cash, S.A.

CASH.MC Q1 2026

Reported: 2026-05-05

Shares dipped 0.5% following Q1 results as currency headwinds and ongoing macroeconomic challenges offset solid organic growth and stable margins, leaving investors cautious despite modest profit gains.

Key takeaways

Revenue declined 3.7% year-on-year to EUR 497 million due to a significant negative foreign exchange impact of 6.6%, partially offset by 3.2% organic growth.
EBITDA margin held steady at 17.3%, down only 10 basis points from Q1 2025, reflecting effective cost control amid inflationary pressures.
Net profit increased 8.1% to EUR 26 million, driven by improved financial results and a lower tax rate (down 300 bps to 42%).
Transformation initiatives remain on track, with related products growing 6.2% and now representing 36.4% of sales, supporting long-term strategy.
Management flagged geopolitical uncertainties and rising fuel costs; fuel price inflation is being passed on to customers with limited near-term margin impact.

View recap

Cogent Communications Holdings, Inc.

CCOI Q1 2026

Reported: 2026-05-05

Shares of Cogent Communications tumbled 22% following Q1 2026 results as investors reacted negatively to continued revenue contraction and cautious outlook, despite modest margin improvements and progress on asset monetization.

Key takeaways

Revenue declined year-over-year, continuing a negative trend linked to the Sprint acquisition integration, though the rate of decline has moderated.
Adjusted EBITDA decreased sequentially by $6.6 million to $70.2 million, with a margin of 29.3%, reflecting some margin expansion year-over-year but pressure sequentially.
Wavelength revenues surged 90.8% year-over-year to $13.6 million with improved customer connections, yet this growth was insufficient to offset broader top-line weakness.
SG&A expenses increased 11% sequentially due to seasonal factors and higher costs including salaries and annual fees.
Management reiterated a multi-year revenue growth target of 6-8% and EBITDA margin expansion of 200 basis points per year but flagged that guidance is not intended as a quarterly or annual forecast.

View recap

Duolingo Inc. Class A Common Stock

DUOL Q1 2026

Reported: 2026-05-05

Duolingo’s shares dropped 6.5% after earnings as investors reacted negatively to the company’s cautious Q2 bookings guidance and margin pressure from increased AI-driven investments, signaling concerns over near-term growth deceleration and margin compression.

Key takeaways

Q1 revenue and bookings grew double digits, with adjusted EBITDA margin expanding to 29%, above the year target.
Daily active users (DAUs) grew 21% YoY, consistent with guidance, led by strong retention improvements and accelerated growth in Asia.
Q2 bookings growth guidance of approximately 6% reflects a tough comp and a significant slowdown from Q1, driving negative sentiment.
Gross margin expected to decline from 71% in Q2 to about 69% by year-end due to rising AI feature costs.
Adjusted EBITDA margin expected to dip slightly to 24% in Q2 before rebounding toward year-end, reflecting deliberate strategic investments.

View recap

EverQuote, Inc.

EVER Q1 2026

Reported: 2026-05-05

EverQuote’s shares surged 64.4% after reporting Q1 results that notably beat expectations across revenue growth, adjusted EBITDA, and marketing efficiency, underscoring accelerating execution and strong market confidence.

Key takeaways

Total revenue grew 15% year-over-year to $190.9 million, driven by robust performance in auto (+13%) and home insurance (+33%) verticals.
Adjusted EBITDA rose 30% year-over-year to a record $29.3 million, reflecting strong operating leverage and disciplined expense management.
Variable marketing dollars reached a record $55.9 million, up 19% year-over-year, with variable marketing margin improving to 29.3%, supported by profitable new traffic channels.
EverQuote is rapidly deploying Agentic AI tools to boost productivity and innovation, aiming to accelerate growth in customer acquisition and marketplace efficiency.
The company maintains a favorable outlook for Q2, emphasizing continued growth momentum and expanding product offerings to strengthen its competitive position.

View recap

Fly Leasing Limited

FLY Q1 2026

Reported: 2026-05-05

Shares of Firefly Aerospace Inc. dropped 6.7% following the earnings release as investors reacted negatively to cautious commentary on future demand scaling and potential margin pressures despite reported record revenue.

Key takeaways

Reported record quarterly revenue of $81 million driven by government programs and lunar lander deployments.
Management highlighted accelerated demand for lunar missions, but emphasized early-stage investments in scaling production and supply chain ramp-up.
Expansion of clean room capacity (4x existing size) signals significant upfront costs that may compress near-term margins.
Execution on Blue Ghost lunar lander and ELECTRA orbiter is progressing, but upcoming missions remain in build and design review phases, delaying revenue visibility.
Broader commentary underscored cautious optimism without firm near-term guidance upgrades, reflecting uncertainty on timing and sustainability of order flow.

View recap

Fabrinet

FN Q3 2026

Reported: 2026-05-05

Shares dropped 6.5% following Fabrinet’s earnings as investors reacted negatively to cautious outlook signals and visible deceleration in datacom revenue alongside ongoing supply constraints.

Key takeaways

Revenue reached a record $1.214 billion, up 39% year-over-year, but datacom revenue grew only 4% annually and declined 6% sequentially, reflecting supply shortages limiting shipments.
Telecom revenue within Optical Communications surged 55% year-over-year, led by a 90% increase in data center interconnect demand.
Non-Optical Communications revenue jumped 52% year-over-year, driven by high-performance compute segment ramping new product generations.
Automotive revenue decreased modestly quarter-over-quarter, partially offset by 9% growth in industrial laser revenue.
Management highlighted ongoing supply-demand imbalances expected to persist into next quarter, tempering near-term visibility despite long-term optimism.

View recap

Hess Midstream LP

HESM Q1 2026

Reported: 2026-05-05

Shares rose 2.8% following Q1 results that aligned with guidance despite winter-related volume headwinds and the expected seasonal maintenance impact. The slight market gain reflects cautious recognition of stable margins and a cash flow outlook upgrade amid operational challenges.

Key takeaways

Q1 adjusted EBITDA was $300 million, down modestly from $309 million in Q4 2025 due to severe winter weather reducing volumes and revenues.
Throughput volumes averaged 430 MMcf/d for gas processing, 119,000 barrels/day for crude terminaling, and 115,000 barrels/day for water gathering, with volumes expected to increase after seasonal maintenance in Q2.
Capital expenditures in Q1 were seasonally low at $10 million, with a 33% reduction in full-year 2026 capex guidance to approximately $100 million, driven by operational efficiencies including Chevron’s longer laterals.
Adjusted free cash flow guidance for 2026 was raised to $910 million–$960 million, a 20% increase year over year at the midpoint, supported by lower capex and cash tax deferral.
Distribution increased 2% (8% annualized for Class A shares) and $60 million in accretive share/unit repurchases were completed, maintaining cash returns while reducing share count.

View recap

Huntsman Corporation

HUN Q1 2026

Reported: 2026-05-05

Huntsman’s shares declined modestly by 1.0% following the quarter, reflecting investor caution amid ongoing margin pressure and uncertainty about sustained demand beyond the near-term order uptick.

Key takeaways

The company successfully raised prices to offset raw material cost inflation, aiming to improve margins from multi-year lows.
Plant operations remained reliable, supporting stronger-than-expected demand into Q2, helped by seasonal factors and customer stockpiling ahead of price increases.
Management highlighted supply chain disruptions, particularly among European customers reliant on Chinese suppliers, contributing to demand shifts.
Visibility beyond June remains limited, with concerns about inflationary pressures tempering longer-term demand outlook.
Regional cost disparities, especially high energy prices in Europe versus lower U.S. natural gas prices, continue to weigh on margin recovery efforts.

View recap

Inspire Medical Systems, Inc.

INSP Q1 2026

Reported: 2026-05-05

Shares dropped 14.9% following the quarter as investors reacted negatively to a revised full-year revenue outlook amid ongoing coding and reimbursement challenges, compounded by headwinds from the new WISER prior authorization program.

Key takeaways

Revenue growth and adjusted operating income improved versus prior year, but underlying operational challenges persist.
Significant coding and reimbursement uncertainties remain, particularly for the Inspire V system, with only partial short-term solutions in place.
Medicare’s new C-code for Inspire V provides some clarity, but broader commercial payer coding remains inconsistent, requiring manual reviews and prior authorizations.
The WISER program introduced prior authorization delays in six states, adversely impacting first-quarter revenue and creating ongoing headwinds.
Management is increasing customer support and education to improve prior authorization success and expects coding and reimbursement trends to stabilize later in the year.

View recap

Lattice Semiconductor Corporation

LSCC Q1 2026

Reported: 2026-05-05

Lattice Semiconductor’s shares rose modestly by 1.1% after reporting solid Q1 results and maintaining confident guidance, but the lack of a stronger market response suggests investors remain cautious about near-term outlook or premium valuation on the upcoming AMI acquisition.

Key takeaways

Q1 revenue grew 42% year over year to $170.9 million, driven by broad strength across compute and communications as well as industrial and embedded end markets.
Compute and communications segment accounted for 62% of revenue, with data center AI demand cited as a key growth driver.
Channel inventory reduced from three months to close to two months, indicating improving supply chain dynamics.
EPS increased 86% year over year, reflecting operating leverage and efficient scaling alongside revenue growth.
Q2 guidance calls for approximately 50% year-over-year revenue growth ($185 million midpoint) and 80% EPS growth, maintaining a confident outlook despite potential market uncertainties related to the AMI acquisition.

View recap

Medifast, Inc.

MED Q1 2026

Reported: 2026-05-05

Shares rose 19.3% as the market rewarded Medifast for its initial signs of stabilization and sequential quarterly revenue growth after three years of decline, driven by solid coach productivity gains and progress in repositioning toward metabolic health.

Key takeaways

First quarter marked the first sequential quarterly revenue growth in three years, signaling a potential turnaround after an extended downturn.
The number of active earning coaches continues to decline but was offset by a second consecutive quarter of year-over-year coach productivity improvements.
Enhanced coach leadership and a higher percentage of coaches acquiring new clients indicate strengthening field engagement.
The company has realigned its cost structure, targeting over $30 million of future savings to support reattaining profitability despite ongoing investments in long-term growth.
Medifast is advancing its metabolic synchronization science, with new clinically backed products planned for rollout later this year, aiming to further differentiate in the shifting weight loss and metabolic health market.

View recap

NextDecade Corporation

NEXT Q1 2026

Reported: 2026-05-05

NextDecade's stock rose 8.8% following the earnings update, driven by progress ahead of schedule and on budget at the Rio Grande LNG facility, along with early sales that reduce near-term exposure to volatile LNG market margins.

Key takeaways

Construction on Trains 1 and 2 is over two-thirds complete, with Phase 1 tracking ahead of guaranteed EPC completion dates.
Early electrical commissioning of Train 1 is underway, supporting first gas expected in H2 2026 and first LNG production in H1 2027.
Early LNG cargo marketing reduced exposure to market price fluctuations by 33%, with over 175 TBtu sold on FOB basis at margins above $3/MMBtu.
Preparations for operations continue with over 400 employees hired and enterprise digital systems going live to support scaling and governance.
Development and permitting for Trains 6 through 8 are progressing, with formal FERC application for Train 6 expected this quarter, in response to sustained long-term demand.

View recap

ON Semiconductor Corporation

ON Q1 2026

Reported: 2026-05-05

ON Semiconductor’s shares declined modestly by 0.3% following Q1 results, reflecting a market assessment of largely in-line execution without significant surprises in guidance or outlook.

Key takeaways

Q1 revenue reached $1.51 billion, and non-GAAP EPS was $0.64, both near the midpoint of guidance.
Gross margin expanded sequentially to 38.5%, marking the third consecutive quarter of improvement.
AI data center revenue grew more than 30% sequentially, indicating strong momentum in this high-growth segment.
Automotive revenue in China grew year over year despite a 6% decline in the domestic passenger vehicle market.
The company maintains a cautious outlook with no explicit upgrades or cuts to guidance, consistent with a view that the recovery cycle has bottomed.

View recap

Pinterest, Inc.

PINS Q1 2026

Reported: 2026-05-05

Pinterest shares rose 10.2% following first quarter results that demonstrated clear progress in user growth and AI-driven engagement, surprising investors with stronger-than-expected operational improvements and margin expansion.

Key takeaways

Revenue surpassed $1 billion, growing 18% year over year, signaling sustained top-line momentum.
Adjusted EBITDA increased to more than $207 million, reflecting improved profitability and operational leverage.
Monthly active users reached 631 million, all logged in, continuing a streak of double-digit user growth for ten consecutive quarters.
AI innovations, including the PinRack model and Canvas image generation, drove meaningful gains in search fulfillment, advertiser cost efficiencies (CPA and CPC down ~180 basis points), and user engagement metrics.
Management remains focused on accelerating monetization and expanding AI-powered shopping features, with ongoing efforts to better capture the value of rising user engagement.

View recap

Palantir Technologies Inc.

PLTR Q1 2026

Reported: 2026-05-05

Shares fell 5.7% after earnings as investor enthusiasm for Palantir’s operational AI platform was tempered by cautious commentary on model reliance risks and the complexity of scaling AI without introducing errors.

Key takeaways

Reported an exceptionally high 85% year-over-year revenue growth and 16% sequential growth, with U.S. revenue doubling at 104% year-over-year.
Highlighted strong adoption of the AIP platform across commercial and government sectors, including major partnerships with GE Aerospace and USDA contracts worth up to $300 million.
Management emphasized the operational risks inherent in scaling AI models—specifically the challenge of avoiding error (“slop”) as token usage increases exponentially.
Margins and long-term model reliability concerns suggest the company faces headwinds in converting AI-driven growth into consistent profitability.
The market likely reacted negatively due to a cautious outlook on the sustainability of AI-driven workflows and the operational complexity of deploying AIP at scale.

View recap

General Electric Company

POR Q1 2026

Reported: 2026-05-05

Shares declined 5.6% as investors reacted negatively to signs of demand deceleration in key segments and weather-related volatility weighing on usage, which contributed to cautious near-term visibility despite management’s reiterated full-year guidance.

Key takeaways

GAAP net income was $45 million ($0.38 per diluted share), while non-GAAP net income stood at $68 million ($0.58 per diluted share), excluding storm restoration and other one-time expenses.
Mild winter weather and lower seasonal usage from residential and small commercial customers negatively impacted results.
Industrial customer demand grew 10% year-over-year, but overall residential/small commercial demand decelerated due to weather and usage softness.
Management is engaging regulators to develop frameworks aimed at mitigating revenue and cost volatility caused by weather, recognizing this as a multiyear effort.
The company reiterated full-year earnings guidance of $3.33 to $3.53 per diluted share, but market reaction suggests skepticism about near-term growth and margin stability.

View recap

Proto Labs, Inc.

PRLB Q1 2026

Reported: 2026-05-05

Shares fell 0.7% after the quarter as investors digested solid top-line growth alongside ongoing operational investments and a cautious tone on 2026 transformation efforts. Despite double-digit revenue growth and margin expansion, the market appears hesitant amid early-stage strategic resets and increased focus on operational scaling.

Key takeaways

First quarter revenue rose 10% year-over-year, driven by strength in CNC machining (+20% growth) and U.S. market (+12%).
Revenue per customer increased 20%, supported by deeper engagement with larger aerospace, defense, and medical clients.
Non-GAAP earnings per share reached a five-year high, driven by margin expansion and operating leverage.
Operational investments include quality improvements in injection molding and the launch of a Global Capability Center in India to support scaling.
A strategic reset in Europe and ongoing organizational changes signal 2026 will be a year focused on transformation rather than acceleration of growth.

View recap

Paramount Skydance Corporation Class B Common Stock

PSKY Q1 2026

Reported: 2026-05-05

Shares dropped 3.9% after earnings as investors reacted negatively to cautious forward indications and visible margin pressures despite ongoing execution on business transformation and content expansion.

Key takeaways

Paramount Skydance is progressing with unifying its streaming platforms, targeting a single integrated service launch by mid-year, aiming to enhance personalization and consumer experience.
Content slate expansion included notable successes such as *Scream 7* becoming the franchise’s highest-grossing film and *Landman* setting a Paramount Plus viewership record.
Streaming engagement remained strong, with over 10 million households consuming 100 million hours of UFC content, and CBS delivered top-rated primetime programs.
The company is focusing on AI and technology integration across ad products and data platforms to drive efficiency and monetization improvements.
Despite operational progress, margin compression and a cautious outlook likely weighed on investor sentiment, contributing to the stock’s decline.

View recap

Repay Holdings Corporation

RPAY Q1 2026

Reported: 2026-05-05

Shares fell 7.5% following Repay Holdings' earnings as investors reacted negatively to signs of deceleration in Consumer Payments growth and a cautious outlook driven by ongoing integration risks related to the Kubra acquisition.

Key takeaways

Revenue grew 4% year-over-year in Q1, reflecting a slowdown compared to stronger 18% growth in the Business Payments segment.
Adjusted EBITDA margins were approximately 43%, supported by operational efficiencies and automation initiatives.
Consumer Payments saw modest revenue gains driven by new enterprise clients and phased rollout of Voice AI, but growth momentum appears tepid.
Business Payments continued solid momentum with 18% revenue growth, fueled by new software partners and an expanding supplier network (+70% year-over-year vendors).
The acquisition of Kubra, expected to close in Q2 with fully committed financing, introduces integration risks and is viewed cautiously despite management optimism.

View recap

Tactile Systems Technology, Inc.

TCMD Q1 2026

Reported: 2026-05-05

Tactile Systems delivered better-than-expected revenue and margin growth, driving a 5.1% stock increase. Strength in Medicare-driven advanced pump sales and successful operational execution on prior authorization rollout supported upside.

Key takeaways

Total revenue rose 23% year over year to $75.3 million in Q1 2026.
Lymphedema revenue grew 23% to $62.2 million, led by Flexitouch sales benefiting from updated Medicare NCD policy.
Medicare channel sales surged 40% year over year, reflecting both policy tailwinds and some order acceleration before new prior authorization rules.
Gross margin expanded by 250 basis points to 76.5%, supporting adjusted EBITDA growth by $4 million to $3.7 million.
Management accelerated AI prior authorization technology rollout to address new Medicare requirements, demonstrating operational readiness amid early implementation challenges.

View recap

Vertex Pharmaceuticals Incorporated

VRTX Q1 2026

Reported: 2026-05-05

Vertex's Q1 results were largely in line with expectations, reflected in a flat market reaction of +0.1%. Despite solid revenue growth and progress across multiple franchises, the stock's muted response suggests investors found limited reasons for enthusiasm beyond steady execution.

Key takeaways

Total product revenue reached $2.99 billion, marking 8% year-over-year growth.
Products in new disease areas, including KASJEVY and GERNAVICS, contributed about 25% of total product revenue growth.
Commercial milestones include AlifTrack surpassing $1 billion in cumulative revenue and over 500 patients starting KASJEVY treatment.
R&D progress featured rapid regulatory submissions for POBI in IgAN and KASJEVY in pediatric sickle cell disease/beta thalassemia, with clinical trials advancing across various indications.
VX-522 mRNA therapy program was discontinued due to tolerability issues, eliminating potential upside from this next-generation CF treatment.

View recap

Earnings Recaps

ALK-Abelló A/S

Prosegur Cash, S.A.

Cogent Communications Holdings, Inc.

Duolingo Inc. Class A Common Stock

EverQuote, Inc.

Fly Leasing Limited

Fabrinet

Hess Midstream LP

Huntsman Corporation

Inspire Medical Systems, Inc.

Lattice Semiconductor Corporation

Medifast, Inc.

NextDecade Corporation

ON Semiconductor Corporation

Pinterest, Inc.

Palantir Technologies Inc.

General Electric Company

Proto Labs, Inc.

Paramount Skydance Corporation Class B Common Stock

Repay Holdings Corporation

Tactile Systems Technology, Inc.

Vertex Pharmaceuticals Incorporated

Community

Earnings Recaps

ALK-Abelló A/S

Prosegur Cash, S.A.

Cogent Communications Holdings, Inc.

Duolingo Inc. Class A Common Stock

EverQuote, Inc.

Fly Leasing Limited

Fabrinet

Hess Midstream LP

Huntsman Corporation

Inspire Medical Systems, Inc.

Lattice Semiconductor Corporation

Medifast, Inc.

NextDecade Corporation

ON Semiconductor Corporation

Pinterest, Inc.

Palantir Technologies Inc.

General Electric Company

Proto Labs, Inc.

Paramount Skydance Corporation Class B Common Stock

Repay Holdings Corporation

Tactile Systems Technology, Inc.

Vertex Pharmaceuticals Incorporated

Community

Trending This Week

Notifications